EUVIMEDDescobrir EUVIMED
Open access

Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study

Yu-Hsin Tsai, Tai-Cheng Hou, Po-Yu Liu, Chih-Jung Chen, Jiunn-Min Wang

In Vivo · 2024 · 38 (4) · 1965-1972

DOI: 10.21873/invivo.13653 ↗

At a glance

Journal article in In Vivo, published online on 2024-06-27. Written by Yu-Hsin Tsai and 4 co-authors. Institution: Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. Major MEDLINE topics: COVID-19, Coinfection, SARS-CoV-2, Anti-Bacterial Agents. Cited 4 times so far (Crossref). The full text is freely available in PubMed Central.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

BACKGROUND/AIM: Bloodstream infections in patients with COVID-19 are linked to higher mortality rates, whilst data on epidemiology and resistance patterns remains scarce to guide management and prevent antibiotic resistance. This research focuses on the prevalence, clinical features, causative microorganisms, and antimicrobial susceptibility of bacterial and fungal secondary bloodstream co-infections in hospitalized patients with COVID-19. PATIENTS AND METHODS: In this retrospective study analysis of 230 patients with COVID-19 from Central Taiwan (June 2021 to June 2022), pathogens were identified via MALDI-TOF MS and Vitek 2 system with Clinical & Laboratory Standards Institute (CLSI) standards. RESULTS: In the cohort, 17.8% experienced bloodstream infections, resulting in a total of 45 isolates from the 41 bloodstream infection patients: predominantly gram-positive bacteria (Staphylococcus and Enterococcus) at 69%, gram-negative at 29% (Escherichia coli and Klebsiella pneumoniae), and fungi at 2%. Infected patients showed significantly elevated levels of white blood count (WBC), C-reactive protein (CRP) and procalcitonin (PCT). Of note, resistance to common antibiotics, such as fluoroquinolones, cephalosporins, and oxacillin was significant, especially in K. pneumoniae, Acinetobacter species, and S. aureus infections. CONCLUSION: Our study highlights the influence of bacterial infections in hospitalized patients with COVID-19. The bacterial infections were discovered to impact the clinical trajectory of COVID-19, potentially exacerbating or mitigating its symptoms, severity and fatality. These insights are pivotal to addressing clinical challenges in COVID-19 management and underscoring the need for tailored medical interventions. Understanding these co-infections is thus essential for optimizing patient care and improving overall outcomes in the post COVID-19 pandemic era.

Subjects

MeSH terms (MEDLINE)

COVID-19CoinfectionSARS-CoV-2Anti-Bacterial AgentsHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTaiwanHospitalizationBacteremiaAged, 80 and overAdultMicrobial Sensitivity TestsDrug Resistance, Bacterial

Author keywords

COVID-19antimicrobial susceptibilitybloodstream infectionmicroorganisms

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Department of Pathology, Jen-Ai Hospital, Taichung, Taiwan, R.O.C.
  • Division of Infection, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.; cjchen1016@vghtc.gov.tw.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan, R.O.C.

Cite

APA

Tsai, Y. H., Hou, T. C., Liu, P. Y., Chen, C. J., & Wang, J. M. (2024). Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study. In Vivo, 38(4), 1965-1972. https://doi.org/10.21873/invivo.13653

Vancouver

Tsai YH, Hou TC, Liu PY, Chen CJ, Wang JM. Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study. In Vivo. 2024;38(4):1965-1972. doi:10.21873/invivo.13653

BibTeX
@article{Tsai2024,
  author = {Tsai, Yu-Hsin and Hou, Tai-Cheng and Liu, Po-Yu and Chen, Chih-Jung and Wang, Jiunn-Min},
  title = {Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study},
  journal = {In Vivo},
  year = {2024},
  volume = {38},
  number = {4},
  pages = {1965--1972},
  doi = {10.21873/invivo.13653}
}
Start for free →